Vivani Medical (VANI) Change in Receivables (2014 - 2020)
Vivani Medical (VANI) posted quarterly Change in Receivables of -$6000.0 for Q2 2020, down 122.22% year-over-year from $27000.0 in Q3 2019, and up 98.68% quarter-over-quarter from -$455000.0 in Q1 2020.
Vivani Medical (VANI) Change in Receivables (2014 - 2020) Analysis & Trends
Vivani Medical's Change in Receivables history runs 7 years deep, the most recent figure standing at -$6000.0 for Q2 2020.
- In Q2 2020, Change in Receivables fell 122.22% year-over-year to -$6000.0; the TTM figure through Dec 2020 stood at -$461000.0 (down 860.42% YoY), while the FY2020 annual figure was -$461000.0, down 860.42% from the prior year.
- Change in Receivables for Q2 2020 stood at -$6000.0, up from -$455000.0 in the prior quarter.
- The five-year high for Change in Receivables was $1.1 million in Q4 2017, with the low at -$1.4 million in Q1 2018.
- The 5-year median for Change in Receivables is -$3333.5 (2016), against an average of -$70611.1.
- The sharpest annual moves came in 2017 and 2020: Change in Receivables jumped 68165.97% in 2017, then plunged 578.95% in 2020.
- Vivani Medical's Change in Receivables stood at -$81000.0 in 2016, then soared by 1460.49% to $1.1 million in 2017, then plunged by 152.72% to -$581000.0 in 2018, then soared by 133.05% to $192000.0 in 2019, then sank by 103.12% to -$6000.0 in 2020.
- Business Quant data shows VANI's Change in Receivables at -$6000.0 in Q2 2020, -$455000.0 in Q1 2020, and $192000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -6,000.00 |
| Jun 30, 2020 | -6,000.00 |
| Mar 31, 2020 | -455,000.00 |
| Mar 31, 2020 | -455,000.00 |
| Dec 31, 2019 | 192,000.00 |
| Dec 31, 2019 | 192,000.00 |
| Sep 30, 2019 | -362,000.00 |
| Sep 30, 2019 | -362,000.00 |
| Jun 30, 2019 | 27,000.00 |
| Jun 30, 2019 | 27,000.00 |
| Mar 31, 2019 | 95,000.00 |
| Mar 31, 2019 | 95,000.00 |
| Dec 31, 2018 | -581,000.00 |
| Dec 31, 2018 | -581,000.00 |
| Sep 30, 2018 | 461,000.00 |
| Sep 30, 2018 | 461,000.00 |
| Jun 30, 2018 | 274,000.00 |
| Jun 30, 2018 | 274,000.00 |
| Mar 31, 2018 | -1.37 Mn |
| Mar 31, 2018 | -1.37 Mn |